Terminated PHASE2 INTERVENTIONAL 2-arm NCT00966654

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery (GLP-1 CABG)

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass Surgery

Sponsor: Johns Hopkins University

Conditions CABG

Interventions GLP-1 (7-36) amide Placebo

Updated 7 times since 2017 Last updated: Jun 29, 2017 Started: Sep 30, 2008 Primary completion: Aug 31, 2009 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI left JHU

Other terminated trials from Johns Hopkins University

See all terminations from Johns Hopkins University

This PHASE2 trial investigates CABG and is currently terminated or withdrawn. Johns Hopkins University leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Aug 2017 — Jun 2018 [monthly]

Terminated PHASE2

Status: Unknown Status → Terminated

▶ Show 2 earlier versions

Feb 2017 — Aug 2017 [monthly]

Unknown Status PHASE2
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States